Jade Biosciences (JBIO) News
NASDAQ: JBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.31+0.25 (+1.66%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
JBIO news summary
We found 2 recent headlines mentioning Jade Biosciences (JBIO): 0 in the past week and 2 in the past 30 days, most often from Seeking Alpha, GlobeNewswire. For price context, JBIO is up 1.66% at $15.31. The most recent story, "Jade Biosciences GAAP EPS of -$0.42", was published by Seeking Alpha on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Jade Biosciences headlines
- Jade Biosciences GAAP EPS of -$0.42Seeking Alpha
- Jade Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateSAN FRANCISCO and VANCOUVER, British Columbia, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on…GlobeNewswire